Literature DB >> 21228932

Epstein-Barr virus positive anaplastic large cell lymphoma: myth or reality?

Ly Ma1, Youval Katz, Kanu P Sharan, Roland Schwarting, Annette S Kim.   

Abstract

The World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissue, 2008 edition, states that anaplastic large cell lymphoma (ALCL) is "consistently negative for Epstein-Barr virus (EBV)". The statement made by the WHO has led to the widespread belief that EBV can have no pathogenic role in ALCL. Herein we report a case of an immunocompetent 35-year-old male who presented with hemophagocytic syndrome secondary to lymphoma for which diagnostic material consisted solely of a bone marrow biopsy. The biopsy demonstrated large anaplastic cells which were uniformly positive for surface CD3, CD30 (strong membranous and Golgi expression), CD45, TIA-1 and Granzyme B but negative for ALK-1. In-situ hybridization was strongly positive for EBER in the large neoplastic cells. The uniformity of CD30 expression and positivity for cytotoxic markers on the anaplastic tumor cells raised the diagnostic possibility of an EBV-associated ALCL, ALK-. Discussion of this case as well as a retrospective review of 64 cases of reported of EBV+ ALCL are presented.

Entities:  

Keywords:  ALK; Epstein-Barr virus; anaplastic large cell lymphoma

Mesh:

Substances:

Year:  2010        PMID: 21228932      PMCID: PMC3016108     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  49 in total

1.  Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients.

Authors:  J S Burgos; F J Vera-Sempere
Journal:  Laryngoscope       Date:  2000-12       Impact factor: 3.325

2.  Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma.

Authors:  Sandhya Agarwal; Uma Ramanathan; Kikkerj N Naresh
Journal:  Hum Pathol       Date:  2002-02       Impact factor: 3.466

3.  Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.

Authors:  Jingwu Xu; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry.

Authors:  Jonathan Juco; Jeannine T Holden; Karen P Mann; Lloyd G Kelley; Shiyong Li
Journal:  Am J Clin Pathol       Date:  2003-02       Impact factor: 2.493

5.  Clusterin expression in malignant lymphomas: a survey of 266 cases.

Authors:  Helene Saffer; Amer Wahed; Georgios Z Rassidakis; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2002-11       Impact factor: 7.842

6.  Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.

Authors:  R Suzuki; Y Kagami; K Takeuchi; M Kami; M Okamoto; R Ichinohasama; N Mori; M Kojima; T Yoshino; H Yamabe; M Shiota; S Mori; M Ogura; N Hamajima; M Seto; T Suchi; Y Morishima; S Nakamura
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

7.  Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas.

Authors:  A A Brink; R L ten Berge; A J van den Brule; R Willemze; A Chott; C J Meijer
Journal:  J Pathol       Date:  2000-08       Impact factor: 7.996

8.  Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH.

Authors:  Sara Calattini; Irini Sereti; Philip Scheinberg; Hiroshi Kimura; Richard W Childs; Jeffrey I Cohen
Journal:  Blood       Date:  2010-08-10       Impact factor: 22.113

9.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

10.  The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

Authors:  Z G Xu; K Iwatsuki; N Oyama; M Ohtsuka; M Satoh; S Kikuchi; H Akiba; F Kaneko
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

View more
  6 in total

1.  Pericardial involvement as an initial presentation of anaplastic large cell lymphoma.

Authors:  Purushothaman Muthusamy; Stephen Ebrom; Stephen D Cohle; Nasir Khan
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

2.  Beneath the Retinal Pigment Epithelium: Histopathologic Findings in Metastatic Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.

Authors:  Atalie C Thompson; Chad M McCall; Alan D Proia
Journal:  Ocul Oncol Pathol       Date:  2018-06-06

3.  Aggressive Subcutaneous Panniculitis-Like CD30+ Peripheral T-Cell Lymphoma with Diffuse EBER Expression.

Authors:  Amandeep Aneja; Raghava LevakaVeera; Viren Patel; Ashish Bains
Journal:  Case Rep Hematol       Date:  2014-07-20

4.  Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.

Authors:  Abdelwahid Saeed Ali; Mubarak Al-Shraim; Ahmed Musa Al-Hakami; Ian M Jones
Journal:  Open Virol J       Date:  2015-11-03

5.  Primary Cutaneous Anaplastic Large-Cell Lymphoma.

Authors:  Nerissa Moodley; Patiswa Nombona; Anisa Mosam
Journal:  Dermatopathology (Basel)       Date:  2019-06-26

Review 6.  Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.

Authors:  Xin-Rui Zhang; Pham-Ngoc Chien; Sun-Young Nam; Chan-Yeong Heo
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.